Scientists test Brain-Boosting pill to fight Alzheimer's in down syndrome
NCT ID NCT07278492
Summary
This early-stage study is testing whether a daily supplement called MIB-626, which boosts a natural body chemical called NAD+, is safe for adults with Down syndrome. The goal is to see if raising NAD+ levels can help prevent or slow the progression of Alzheimer's disease, which is very common in this population. Over 28 days, 24 participants will take either the supplement or a placebo pill, and researchers will monitor their safety and measure NAD+ levels in their blood and brain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOWN SYNDROME (DS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.